More Accurate Insight into the Incidence of Human Rabies in Developing Countries through Validated Laboratory Techniques by Dacheux, Laurent et al.
Viewpoints
More Accurate Insight into the Incidence of Human
Rabies in Developing Countries through Validated
Laboratory Techniques
Laurent Dacheux
1*, Supaporn Wacharapluesadee
2, Thiravat Hemachudha
2, Franc ¸ois-Xavier Meslin
3,
Philippe Buchy
4, Jean-Marc Reynes
5, Herve ´ Bourhy
1
1Institut Pasteur, Dynamics and Host Adaptation Unit, National Reference Centre for Rabies, WHO Collaborative Centre for Reference and Research on Rabies, Paris,
France, 2Molecular Biology Laboratory for Neurological Diseases, Department of Medicine, Chulalongkorn University Hospital, Bangkok, Thailand, 3Neglected Zoonotic
Diseases, Department of Neglected Tropical Diseases, Cluster HIV/AIDS, Malaria, Tuberculosis and Neglected Tropical Diseases (HTM), WHO Headquarters, Geneva,
Switzerland, 4Institut Pasteur du Cambodge, Virology Unit, Cambodia, 5Centre Pasteur du Cameroun, Virology Unit, Cameroon
How to Improve Human Rabies
Diagnosis in Developing
Countries
Over the past 10 years, new techniques
and protocols have been proposed for rabies
diagnosis, especially in humans. However,
the reported number of laboratory-con-
firmed human rabies cases remains limited
and underestimates the real impact of this
neglected zoonotic disease, particularly in
enzo-epizootic areas of Asia and Africa [1].
The regular reporting of diagnostic data
through the structures of the World Orga-
nization for Animal Health and the World
Health Organization (WHO) (using the
RABNET network, for example), together
with the importance of the status of rabies as
a notifiable disease in all countries, remain
crucial for the surveillance and control of
rabies, especially in humans. There is clearly
a need to improve diagnostic tools appropri-
ate for the facilities in these countries. This
paper provides a review of recent publica-
tions relating to the evaluation of methods
for human rabies diagnosis in developing
country settings in order to highlight the
sampling methods and techniques that are
likely to give the most reliable results.
In their recent review entitled ‘‘Emerging
technologies for the detection of rabies virus:
challenges and hopes in the 21st century’’,
Fookset al.[2] provide information on some
of the latest techniques to detect rabies virus
or nucleic acid in diagnostic samples.
However, additional major techniques not
mentioned by Fooks et al. [2] are also
available, some concerning recent studies
addressing the broader challenge of human
rabies diagnosis in developing countries,
which we aim to describe here.
A Key Step: Selection of
Biological Samples
Several biological samples can be used for
intra-vitam diagnosis of human rabies:
saliva, cerebral spinal fluid (CSF), [2] but
also skin biopsies containing hair follicles
collected at the nape of the neck, extracted
hair follicles, tears, and urine [3–5]. The
collection of brain biopsy samples [6] should
be discouraged for intra-vitam diagnosis and
should be restricted to post-mortem diagno-
sis. Skin biopsies can also be used for the
post-mortem diagnosis of rabies encephalitis
to replace brain biopsy when the latter is not
feasible (which is the case in most of enzootic
areas in Asia and Africa where cerebral
brain biopsies are rarely authorized by the
patient’s family) [3,7]. Because the viral
shedding in saliva, CSF, and urine is
suggested to be intermittent, multiple differ-
ent samples (e.g., skin, saliva, urine) must be
collected and analyzed by molecular meth-
ods for an intra-vitam rabies diagnosis.
However, the sensitivity of testing only one
skin biopsy per patient has been shown to be
$98% [3], and it is possible to achieve
maximal sensitivity (up to 100%) for furious
rabies encephalitis by collecting and testing
three serial daily saliva samples per patient
[3]. Viral RNA detection from paralytic
rabies patients is also possible, although the
sensitivity may be lower. In a recent study
conducted in Thailand, the sensitivity of
detection of paralytic and furious rabies was
50% (n=6) and 92% (n=50) per patient,
respectively [4,5]. A summary of the
sensitivity results obtained for different
biological samples using molecular methods
is shown in Table 1. Two sets of recom-
mendations for sample collection in current
use in reference laboratories in both devel-
oped and developing countries are shown in
Tables 2 and 3.
Preservation of Samples
It is also essential to mention the
importance of the conditions required for
the shipment and preservation of speci-
mens, especially when molecular tech-
niques will be used. The use of glycerol as
a transport medium is convenient for brain
biopsy samples [6]. However, the mainte-
nance of a cold chain (+4uCo r220uC)
remains essential when using samples for
the intra-vitam diagnosis of rabies [6].
These preliminary steps still pose a chal-
lenge in most developing countries. A
reliable system for transporting samples
from hospitals to reference laboratories has
to be organised. The use of commercial
storage media for nucleic acid [8], RNA
extraction reagents [9], or filter paper
technology [10] might be good alternatives.
Preparation of Samples
Different protocols have proved effective
for the preparation of samples for viral
RNA detection by nucleic acid extraction
and reverse transcription (RT) [3,11–14].
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lications [2,6], strict quality control mea-
sures must be followed to avoid false
positive or negative results. This includes
the use of appropriate controls for eachstep
of the process (e.g., using endogeneous
RNA as beta-actin or ribosomial 18SRNA,
or other spiked and/or synthetic controls).
This applies to RT, polymerase chain
reaction (PCR), and other molecular tech-
niques such as nucleic acid sequence-based
amplification (NASBA) and loop-mediated
isothermal amplification (LAMP) tech-
niques. Positive results of viral RNA in
samplesshouldbeconfirmedbysequencing
to avoid false positives, although it is
recognised that sequencing capacity may
not yet be available in most developing
country settings. This also permits geno-
typing of viral strains, which is useful for
epidemiological surveillance.
Choice of the Most Appropriate
Molecular Techniques for Viral
RNA Detection
Molecular techniques for the detection of
rabies and rabies-related lyssaviruses usually
use PCR methods targeting the viral nucle-
oprotein gene as indicated by Fooks et al. [2].
However, another region of the lyssavirus
viral genome, the polymerase gene, can also
be used. This gene encompasses several
nucleotide blocks (such as block III) that
have been highly conserved during lyssavirus
evolution [15]. A new RT, hemi-nested PCR
(RT-hnPCR) protocol employing this region
was developed and standardized in three
laboratories, one in France and two in
developing countries where rabies is still
endemic (Cambodia and Madagascar) [3].
Using this RT-hnPCR, it was possible to
Table 1. Description of Biological Samples Analyzed for Molecular Diagnosis of Human Rabies in Large Cohorts of Suspected or
Confirmed Rabid Patients in Local Laboratory Conditions.
Samples
Technique
(Target Gene) Reference
Country Where the
Study Was Performed
Sensitivity (Number
of Samples tested) Commentary
Saliva RT-hnPCR
(L gene)
[3] France, Madagascar,
Cambodia
70.2% (n=84) A sensitivity of 100% was observed for
three serial daily saliva samples per
patient with encephalitic rabies.
Liquid saliva (a volume of 200 mLf o r
analysis) is preferable to saliva swab.
RT-PCR
(N gene)
[16] France 30% (n=37) A volume of 200 mL was used for
analysis. A proteinase K lysis step was
included.
NASBA
(N gene)
[4,5] Thailand 75.8% (n=62) A volume of 200 mL was used for
analysis.
RT-nPCR
(N gene)
[17] India 37.5% (n=24) Pool of three saliva samples collected
at intervals of 4–5 h.
Confirmation of rabies with reference
technique (FAT) is not mentioned in
this study.
RT-qPCR (SYBR Green)
(N gene)
[17] India 75% (n=24) Pool of three saliva samples collected
at intervals of 4–5 h.
Confirmation of rabies with reference
technique (FAT) is not mentioned in
this study.
Skin biopsy RT-hnPCR
(L gene)
[3] France, Madagascar,
Cambodia
98.3% (n=60) Collected at the nape of the neck,
containing hair follicles.
A sensitivity of 100% (n=33) was
obtained at hospital admission and
97.2% (n=36) at hospital discharge or
death.
RT-PCR
(N gene)
[7] Brazil 70% (n=10) Most neck-skin biospy samples were
collected post-mortem (8/10).
Extracted hair NASBA
(N gene)
[4,5] Thailand 50% (n=26) At least 20 hairs have to be collected.
Urine RT-hnPCR
(L gene)
[3] France, Madagascar,
Cambodia
9.5% (n=63) The difference in sensitivity found in
these studies seems to be due to
difference ofvolumeoftested samples.
At least 1 mL has to be collected and
analyzed (as amount of viral RNA
found in this samples is low).
NASBA
(N gene)
[4,5] Thailand 39% (n=41)
CSF RT-PCR
(N gene)
[16] France 8% (n=12) A volume of 200 mL was used for
analysis. A proteinase K lysis step was
included.
NASBA
(N gene)
[4,5] Thailand 43.3% (n=30) A volume of 200 mL was used for
analysis.
FAT, fluorescent antibody test; hnPCR, hemi-nested PCR; L, polymerase; N, nucleoprotein; NASBA, nucleic acid sequence-based amplification; nPCR, nested-PCR; PCR,
polymerase chain reaction; qPCR, real-time PCR; RT, reverse transcription.
doi:10.1371/journal.pntd.0000765.t001
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post-mortem) using saliva, urine, and skin
biopsy specimens collected from a large
cohort of patients with suspected rabies (51
patients enrolled and 425 samples collected
and analyzed). In this study, a sensitivity of
more than 98% was obtained using single
skin biopsy sample, irrespective of the time of
collection (i.e., from 1 day after the onset of
symptoms to just after death), and of 100%
when at least three successive saliva samples
per patient were analyzed. This study
confirmed and complemented other results
obtained by RT-PCR [7,16,17] and by
NASBA techniques [11,18], but not all were
mentioned by Fooks et al. [2]. All these
results indicated that it is now possible to
perform a reliable intra-vitam diagnosis of
human rabies by collecting serial saliva
samples [3,5,11,17,18] or simply a skin
biopsy from the nape of the neck, which
shows a high sensitivity even when taken
right at the time of admission [3,7]. RNA
d e t e c t i o ni ns k i nb i o p s yt i s s u e si sm o r e
sensitive than in extracted hair follicles
(98% versus 53%), although the latter is
easiertoperform[4,5].Thesestudiesprovide
a clear demonstration of the feasibility of
using molecular methods for human rabies
diagnosis in developing countries (Brazil,
Cambodia, India, Madagascar, Thailand,
etc.). These techniques have also the poten-
tial to improve rabies surveillance, particu-
larly in countries where the incidence is
expected to be high, and the only evaluations
have been made using mathematical models
reliant on extrapolation [1,19].
Rabies-Specific ELISA
Techniques
ELISA techniques can be used for the
detection of rabies antigens or anti-rabies
IgG. These tests are rapid, cheap, easy to
use, and safe because they do not require
the use of infectious virus, making them
suitable for use in developing countries.
Antigen Detection
Apart from the recently developed
direct rapid immunohistochemical test
(dRIT) [20] and rapid immunodiagnostic
test (RIDT) [21] for rabies antigens
detection, a validated ELISA for the rapid
post-mortem detection of antigen in brain
samples is also available but was not
mentioned by Fooks et al. [2]. It has been
evaluated under field conditions in differ-
ent countries [22–25] and its use is
recommended by the WHO [6]. Another
reliable, rapid, and transferable ELISA
method named WELYSSA is designed to
detect lyssaviruses belonging to all seven
genotypes circulating in Europe, Africa,
Asia, and Oceania [26,27]. Performance
of both of them have been compared to
Table 2. National Recommendations from the NRC Rabies, WHO-CC for Reference and Research on Rabies, France, Concerning
Biological Samples Collected for Diagnosis of Human Rabies.
Intra-Vitam Diagnosis of Human Rabies
Samples
Sensitivity Considering the Clinical
Evolution of the Patient (in Days
following the Onset of Symptoms) Comments
a Storage
Technique
(Reference)
0–8 Days .8 Days
Saliva (1 mL or saliva
swabs)
High High At least three saliva samples collected
at intervals of 3–6 hours.
Liquid saliva is preferable to saliva
swabs.
220uC/280uC RT-hnPCR [3]
Urine (at least 1 mL) Low Low At least three urine samples collected
in an interval of 3–6 hours.
220uC/280uC RT-hnPCR [3]
Skin biopsy (diameter
of 4 mm, total volume
of 20 mm
3)
High High Skin biopsy collected at the
nape of the neck, with hair follicles,
using biopsy punch (Stiefel).
220uC/280uC RT-hnPCR [3]
Serum (500 mL) Low Average Sample collection can be repeated,
depending on the length of survival
period (1–2 samples per week).
+4uC/220uC RFFIT [31] and/or
ELISA [3,6,33]
CSF (.300 mL) Low Average Sample collection can be repeated,
depending on the length of survival
period (1–2 samples per week).
220uC/280uC RT-hnPCR [3]; RFFIT [31]
and/or ELISA [3,6,33]
Post-Mortem Diagnosis of Human Rabies
Samples Sensitivity Comments Storage Technique (Reference)
Brain biopsy High Brain biopsy collected via the orbital route
with Tru-Cut biopsy needles for soft tissues
with manual clip (Allegiance) or via the occipital
route using lumbar puncture needles.
+4uC/220uC FAT [28]; RTCIT [29];
WELYSSA [26,27];
RT-hnPCR [3]
Skin biopsy (diameter
of 4 mm, total volume
of 20 mm
3)
High Skin biopsy collected at the nape of the neck,
with hair follicles, using biopsy punch (Stiefel).
220uC/280uC RT-hnPCR [3]
aA minimum of three serially collected saliva samples and one skin biopsy from the nape of the neck are required for intra-vitam diagnosis of human rabies. This permits
a sensitivity of 100% in patients presenting with encephalitic rabies ($98% with skin biopsy alone and 100% with serial saliva samples). Skin biopsy samples can be
collected irrespective of the time after the onset of symptoms. Analysis of additional samples may be advantageous. It includes RNA detection in serially collected urine
and CSF samples, and rabies antibody measurement in serum and CSF. Rabies antibody detection is variable but increases with time after onset of symptoms (.8 days)
and can be informative with atypical or non-classical rabies. After collection, all samples have to be stored at 220uC/280uC before shipment. Storage at +4uC or on ice
should not exceed a few hours (,6 h). All specimens should be shipped at 220uCo r280uC.
FAT, fluorescent antibody test; RFFIT, rapid fluorescent focus inhibition test; RTCIT, rapid tissue culture infection test; RT-hnPCR, reverse transcription hemi-nested
polymerase chain reaction; WELYSSA, ELISA dedicated to lyssavirus antigen detection.
doi:10.1371/journal.pntd.0000765.t002
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sis, i.e., the gold standard fluorescent
antibody test (FAT) [28] for rabies anti-
gens detection and the rapid tissue culture
infection test (RTCIT) [29] for viral
isolation (which should replace the mouse
inoculation test [30], according to WHO
recommendations). Results demonstrated
a high concordance in terms of sensitivity
and specificity [22,26,27].
Antibody Detection
An ELISA for antibody detection is also
recommended by the WHO for testing
serum or CSF from patients with rabies
encephalitis, but mainly for assessment of
the immune status of vaccinated patients
[6] especially when the reference methods,
the rapid fluorescent focus inhibition test
(RFFIT) [31] or fluorescent antibody virus
neutralization test (FAVN) [32], cannot be
performed, as is usually the case in deve-
loping countries. Although not mentioned
in [2], several previously published studies
have compared the sensitivity of such
methods to standardized reference meth-
ods [33–35]. In particular, a second
generation ELISA test, the Platelia Rabies
II (Bio-Rad), has been favourably evaluat-
ed in a multicentric study [33] and it is
used in several developing countries (Viet-
nam, Cambodia, Senegal, Morocco, Ma-
dagascar) [36]. This shows that these
methods can be easily transferred and
used in laboratories that do not have the
facilities for tissue culture or viral produc-
tion techniques.
Conclusion
As underlined by Fooks et al. [2], the
development of new molecular tools for
the detection of rabies virus, such as
microarrays for lyssavirus detection
[37,38] or antibody titrations using lenti-
viral pseudotypes [39] are aimed at
improving rabies surveillance and control
activities. However, their applicability in
laboratories in most rabies-endemic coun-
tries is debatable. On the other hand,
validated, robust techniques already exist
and should be transferred to these regions,
monitored by quality control and regular
interlaboratory evaluations. These include
methods for viral isolation using RTCIT
[29], and for antigen detection with
ELISA tools [26,27], dRIT [20], RIDT
[21], and the gold standard FAT tech-
nique [28]. International programmes of
networking, collaboration, training, and
proficiency testing of these techniques
should be further encouraged [40,41].
Molecular diagnostic tools such as RT-
PCR, real-time PCR, or other techniques
such as NASBA [11,18] or LAMP [42]
should be made available more widely for
the intra-vitam and post-mortem diagnosis
of human rabies in rabies-endemic coun-
tries. An example of successful sharing and
transferring of these molecular techniques
between laboratories in both developed
and developing countries has already
demonstrated its feasibility [3]. The choice
of the most relevant biological samples to
collect and analyze remains essential and
has to be clearly defined. We therefore
provide recommendations from two refer-
ence laboratories concerning biological
samples collection for human rabies diag-
nosis (Tables 2 and 3). In particular,
analysis of three serially collected saliva
samples and one skin biopsy taken from
the nape of the neck offer the highest level
of sensitivity. Analysis of other samples
Table 3. National Recommendations from the WHO-CC for Research and Training on Viral Zoonoses, Thailand, Concerning
Biological Samples Collected for Diagnosis of Human Rabies.
Intra-Vitam Diagnosis of Human Rabies
Samples
Sensitivity Considering the Clinical
Evolution of the Patient (in Days
following the Onset of Symptoms) Comments
a Storage
Technique
(Reference)
0–8 Days .8 Days
Saliva (1 mL or
saliva swabs)
High High Collected once daily. Repeat
testing if result is negative.
Liquid saliva is preferable to
saliva swabs.
220uC/280uC NASBA [11,18];
TaqMan RT-PCR [43]
Urine (at least 2 mL) Average Average Collected once daily. Repeat
testing if result is negative.
Fresh urine is preferable to
stored samples.
220uC/280uC NASBA [11,18];
TaqMan RT-PCR [43]
Extracted hair (at
least 20 follicles)
Average Average Collected once daily. Repeat
testing if result is negative.
220uC/280uC NASBA [11,18];
TaqMan RT-PCR [43]
CSF (1 mL) Average Average Collected once daily. Repeat
testing if result is negative.
220uC/280uC NASBA [11,18];
TaqMan RT-PCR [43]
Post-Mortem Diagnosis of Human Rabies
Samples Sensitivity Comments Storage Technique (Reference)
Brain biopsy/autopsy High Brain biopsy collected via the orbital route
with use of Tru-Cut biopsy needle (if full
autopsy cannot be performed). In case of
standard autopsy procedure, sample of
brainstem region must be included.
+4uC/220uC FAT [28]; NASBA [11,18];
TaqMan RT-PCR [43]
aSamples from all sources should be examined simultaneously due to the intermittent shedding of virus. If not possible, at least thrree of four less-invasive samples—
saliva, extracted hair follicles, and urine—should be collected. Repeat testing if the first result is negative and test for other etiologic agent(s). RNA detection may be
less sensitive on patient with paralytic rabies. Detection of rabies antibody is not sensitive in serum (approximately 25%) and CSF (none was found positive even 3
weeks after onset) in Asian dog related cases. Therefore, antibody detection-based assays are not recommended in this protocol. All specimens should be transported
immediately (on ice) and if not possible, should be stored at +4uC for no longer than 24 h or at 220uCo r280uC (preferable) if storage time is longer.
FAT, fluorescent antibody test; NASBA, nucleic acid sequence-based amplification; RT-PCR, reverse transcription polymerase chain reaction.
doi:10.1371/journal.pntd.0000765.t003
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Stringent quality control measures are
required to avoid false positive results
due to the high sensitivity of PCR and
NASBA techniques [6]. As underlined by
previous publications [2,13], another ma-
jor limitation is the lack of international
standards for sensitivity determination of
these techniques, making comparisons
difficult. Until these standards are devel-
oped, we strongly urge that only molecular
techniques that have been evaluated in
local laboratories in rabies-enzootic coun-
tries are used on appropriate samples for
human rabies diagnosis [6]. Proposing a
list of technological parameters character-
izing these methods independently from
the description of biological samples and
laboratory environments for which they
are designed could result in a misrepre-
sentation of the future development of
human rabies laboratory diagnosis in the
developing world.
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